In vitro antimicrobial activity of propolis dry extract

L. Drago, B. Mombelli, E. De Vecchi, M. C. Fassina, L. Tocalli, M. R. Gismondo

Research output: Contribution to journalArticlepeer-review


In this study the antibacterial and antifungal properties of propolis, a natural product of bees, have been investigated against different pathogens. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined according to NCCLS standards on 320 strains including Staphylococcus aureus, Group A beta-hemolytic streptococci, Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa and Candida albicans. Time-kill curves were assessed for susceptible microorganisms, testing 0, 0.5, 1, 2, 4 x MIC for propolis, by counting viable bacteria after 0, 3, 6, 24 hours and viable yeasts after O, 3, 6, 24 and 48 hours. Propolis showed good antimicrobial activity against most of the isolates, particularly S. pneumoniae, H. influenzae and M. catarrhalis, but not against Enterobacteriaceae. Time-kill curves demonstrated bacteriostatic rather than bactericidal activity of propolis, the latter being evident only at high concentrations.

Original languageEnglish
Pages (from-to)390-395
Number of pages6
JournalJournal of Chemotherapy
Issue number5
Publication statusPublished - 2000


  • Bacteria
  • Microbial sensitivity tests
  • Propolis
  • Respiratory tract infections
  • Yeasts

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)


Dive into the research topics of 'In vitro antimicrobial activity of propolis dry extract'. Together they form a unique fingerprint.

Cite this